Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Mephipen Capsules 250mg*


May be acceptable

May be acceptable
Mephipen Capsules 250mg* :
Type Medicine Non Marketed
Originator G
Agent Mephico
Distributor Mephico
Laboratory Mephico Laboratories
Responsible Party Mephico SAL
Origin Lebanon
Manufacturer Mephico SAL*
Manufacturing Type G
Origin Lebanon
ATC J01CA01

Your comment will appear shortly after approval

Mephipen Capsules 250mg* :

Revision Date : 21/10/2015


Effect Frequency
Anaphylaxis Rare
Bleeding time prolonged Rare
Diarrhoea (Diarrhea) Not known
Erythema multiforme Rare
Haemolytic anemia Rare
Hemorrhagic colitis Rare
Hepatitis Rare
Interstitial nephritis Rare
Jaundice cholestatic (Cholestatic icterus) Rare
Leucopenia (Leukopenia) Rare
Lyell Syndrome (Toxic epidermal necrolysis) Rare
Nausea Not known
Prothrombin time prolonged Rare
Pruritus Uncommon
Pseudomembranous colitis Rare
Purpura Not known
Serum transaminase increased Not known
Skin rash Uncommon
Stevens-Johnson syndrome Rare
Thrombocytopenia (Thrombopenia) Rare
Urticaria Uncommon
Vomiting Not known

Different Units By MoH Code

Mephipen Capsules 250mg*  MoH 4526 :
Form Capsule, hard
Package Size Box of 16
Strength 250mg
NSSF ✘
Quarantine ✘
Reg. Number 22068
Submission date 01/01/1973
Registration Year 1973
Archived Date 2008


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info